Day, Emily
Eldred-Evans, David
Prevost, A. Toby
Ahmed, Hashim U.
Fiorentino, Francesca
Article History
Received: 4 June 2021
Accepted: 18 November 2021
First Online: 18 March 2022
Declarations
:
: The IP1-PROSTAGRAM study was approved by the UK National Research Ethics Committee (reference 18/LO/1338). The study was conducted in full conformity with the seventh revision of the 1964 Declaration of Helsinki. Written informed consent was obtained before enrolling a patient to the study and before any procedure was undertaken.
: Not applicable.
: HU Ahmed reported receiving grants from Wellcome Trust, the BMA Foundation for Medical Research, and The Urology Foundation during the conduct of the study and grants and personal fees from Sophiris Biocorp, Sonacare Inc., and Boston Scientific (previously Galil and BTG) and grants from Trod Medical, Prostate Cancer UK charity, NIHR, MRC (UK), Cancer Research UK charity, and Imperial Health Charity outside the submitted work. D Eldred-Evans reported receiving grants from the BMA Foundation for Medical Research, The Urology Foundation, and the Royal College of Surgeons of England during the conduct of the study; grants from Imperial Health Charity outside the submitted work.